Hasil Pencarian  ::  Simpan CSV :: Kembali

"Penyakit kardiovaskuler merupakan salah satu penyebab kematian global. Tindakan reperfusi dengan Intervensi Koroner Perkutan Primer (IKPP) adalah tatalaksana untuk revaskularisasi, namun tindakan ini memiliki efek paradoks berupa cedera iskemik pasca reperfusi yang meningkatkan morbiditas dan mortalitias. Mekanisme patogenesis cedera reperfusi yaitu respon inflamasi melalui pelepasan sitokin proinflamasi salah satunya IL-1b. Penelitian ini bertujuan mengkaji perubahan IL-1b pada serum pasien infark miokard akut-elevasi segmen- ST (IMA-EST) yang menjalani IKPP sebelum dan pasca 48 jam tindakan reperfusi dengan pemberian kolkisin. Penelitian melibatkan 64 subjek terdiri dari 30 subjek kelompok kolkisin dan 34 subjek kelompok plasebo. Hasil penelitian menunjukkan peningkatan kadar IL-1b pasca 48 jam IKPP pada kedua kelompok  dengan delta perubahan pada kelompok kolkisin 0,4 pg/mL (-0,2 – 11,3 pg/mL) dan kelompok kontrol 0,3 pg/mL (-1,2 – 14,0 pg/mL), namun tidak didapatkan perbedaan bermakna antar kedua kelompok (p=0,136). Penelitian ini merupakan penelitian pertama yang menilai efek kolkisin terhadap perubahan kadar IL-1b pada pasien IMA-EST yang menjalani IKPP, sehingga dapat digunakan sebagai acuan bagi penelitian selanjutnya.

---

Cardiovascular disease is one of the leading causes of death globally. Reperfusion with Primary Percutaneous Coronary Intervention (PCI) is a management for revascularisation, but it has a paradoxical effect of post-reperfusion ischaemic injury that increases morbidity and mortality. Pathogenesis of reperfusion injury is an inflammatory response through release of proinflammatory cytokines, including IL-1b. This study aims to assess levels of IL-1b changes in serum of ST-elevation acute myocardial infarction (STEMI) patients who underwent PCI before and after 48 hours of reperfusion action with colchicine administration. The study involved 64 subjects consisting of 30 subjects in colchicine group and 34 subjects in placebo group. Study results showed an increase in IL-1b levels after 48 hours of PCI in both groups with delta changes in colchicine group of 0.4 pg/mL (-0.2 – 11.3 pg/mL) and control group of 0.3 pg/mL (-1.2 – 14.0 pg/mL), but there was no significant difference between the two groups (p=0.136). This is the first study to assess the effect of colchicine on levels of IL-1b changes in STEMI patients undergoing PCI, so it can be used as a reference for future studies."

"Latar Belakang. Cedera Reperfusi Iskemia merupakan eksaserbasi paradoks mengakibatkan disfungsi dan kematian sel setelah aliran darah direstorasi ke jaringan yang sebelumnya iskemia. Pada iskemia tungkai akut, reperfusi menimbulkan reaksi kompleks melibatkan inflamasi lokal maupun sistemik dengan dampak lokal sindroma kompartemen dan dampak sistemik berupa disfungsi hingga kegagalan multi organ. Platelets activating factors (PAF) sebagai mediator inflamasi pospholipid mempunyai efek fisiologis yang poten dan beragam, sehingga meningkatkan respon inflamasi pada cedera reperfusi iskemik.Berbagai upaya untuk mencegah dan memperingan cedera reperfusi iskemik, antara lain penggunaan prosedur ischemic preconditioning, antioksidan dan terapi anti-sitokin telah diteliti namun hasil dan manfaat klinisnya belum memuaskan. PTX, phosphodiesterase nonspesifik derivat xanthine, memperlihatkan efek penekanan inflamasi dan menghambat interaksi lekositendotel yang menjanjikan dalam mencegah cedera reperfusi. Namun hasil penelitian mengenai peran pentoxifylinne dalam menekan reaksi inflamasi melalui penekanan PAF pada iskemia tungkai akut tidak konsisten. Sehingga penelitian ini bertujuan untuk menilai peran PTX dalam mengurangi cedera reperfusi melalui penekanan mediator inflamasi PAF pada hewan coba kelinci dengan Reperfusi Iskemia tungkai akut.Metodologi. Dilakukan tindakan iskemik tungkai kiri selama 3 jam yang diikuti 2 jam periode reperfusi pada 10 ekor kelinci New Zealand White jantan yang dibagi menjadi 2 kelompok (kelompok pentoksifin dan kelompok kontrol) secara acak. Pada kelompok perlakuan diberikan PTX 30 menit sebelum reperfusi dengan dosis initial bolus 40 mg/kgBB diikuti dengan dosis rumatan 1 mg/kg BB/jam hingga 3 jam periode reperfusi. Pada kelompok kontrol diberikan cairan garam fisiologis dengan kecepatan dan volume yang sebanding. Tindakan Iskemik dilakukan dengan oklusi arteri iliaka komunis sinistra mengunakan klem selama 3 jam kemudian dilanjutkan dengan restorasi aliran darah. Pengambialn sampel untuk pemeriksaan kadar PAF dilakukan pada 2,5 jam iskemik dan pada 2 jam reperfusi.Hasil. Pada periode Iskemik dua jam tiga puluh menit tidak mengakibatkan perbedaan bermakna (p=0,754), kadar rerata PAF pada kelompok PTX 13,09 ± 0,41 pg/mL dan kelompok kontrol I3,38 ± 0,28 pg/mL. Pada jam ke dua tindakan reperfusi ditemukan perbedaan bermakna (p=0,009) kadar rerata PAF dari kelompok PTX menurun menjadi 11,36±0,78 pg/mL dan kelompok kontrol meningkat menjadi 25,5±0,78 pg/dL.Kesimpulan. PTX menurunkan kadar PAF plasma kelinci dengan cedera reperfusi iskemikia tungkai akut.

---

Background. Ischemic reperfusion injury is a paradoxical exacerbation of cell dysfunction and death following the restoration of blood flow to previously ischemic tissue. Restoration of blood flow is essential to salvage ischemic tissue, however reperfusion itself paradoxically causes further damage to the ischemic tissue, threatening function and viability both organ local and distal through the inflammation response.

In Acute limb ischemia, there are essentially two components: a local component that can result in increasing the regional damage from ischemia inflammatory responses which may result in local syndrome, compartment syndrome, and systemic syndrome, multi organ dysfunction and failure.

Several method and attempt had been studied and performed to prevent and attenuate reperfusion injury such as, ischemic preconditioning, antioxidant, and anti-cytokine therapy, but their clinical benefit were not satisfactory. Pentoxifylline has emerged as an agent that may attenuate inflammation response through several mechanisms. However, studies on PTX and its function to prevent and attenuate inflammation response through attenuating PAF in acute limb ischemic were not consistent. In this study the role of PTX and its function to prevent and attenuate inflammation response through attenuating PAF in acute limb ischemic was investigated.

Methods. Acute limb ischemia in the left lower limbs of 10 New Zealand White male rabbit were performed for 3 hour followed by 2 hours period of ischemia. The rabbits were randomly separated into 2 groups of five (group pentoxifylinne and group control). The Pentoxifylline group was given PTX 40 mg/kg bolus half an hour prior to reperfusion followed by maintenance dose 1 mg/kg/hour until 2 hour post reperfusion, while the control group was given normal saline solution with comparable volume and rate administration. Acute limb Ischemic procedure was performed by direct occlusion of the left femoral artery using non traumatic clamp and followed by releasing the clamp after 3 hours of occlusion. Level of PAF were measured after 2.5 hour of ischemic period and after 2 hours of reperfusion period.

Results. After 2.5 hours of ischemic period, the mean PAF levels did not show any significant difference (p=0.754). The mean PAF level of pentoxifylline group 13.09f0.41 pg/mL, while the mean PAF level of control group 13.38±0.28 pg/mL, After 2 hours period of reperfusion, there were significant differences of mean PAF level between the two groups (p=0.009). The mean PAF level in the control group increase by 12.1 110.79 to became 25.5±0.78 pg/dL, while the mean PAF level of the PTX group decrease by 1.73f1.1 pg/mL and became 11.36±0.78 pg/m L.

Conclusion. PTX decreased the PAF level in rabbits with acute limb ischemic reperfusion injury."

"Latar Belakang: Komplikasi tindakan revaskularisasi pasca suatu periode iskemik mulai menjadi perhatian kalangan medis sejak awal abad ke-20. iskemik tungkai akut merupakan masalah kegawatan kardiovaskular dan tindakan reperfusi terhadap jaringan yang iskemik ternyata sexing memperburuk cedera jaringan yang ada, bahkan sampai dilakukan amputasi. Pada ceders reperfusi iskemik (R-1) terjadi perubahan sifat hemoreologi darah (hematokrit, viskositas, dan deformitas set darah merah). Pentoksifilin (PTXF) mempunyai kemampuan memperbaiki cedera reperfusi dengan meningkatkan aliran darah perifer, memperbaiki deformitas sel darah merah, menurunkan viskositas darah, dan menekan agregasi platelet. Tujuan Penelitian: Untuk mengetahui pengaruh pemberian PTXF terhadap faktor hemoreologi darah pada cedera R-I tungkai akut. Metode: Penelitian dilakukan pada kelinci jantan ras New Zealand White Rabbit (NZW) yang berasal dari 1 galur sebanyak 10 ekor usia 5 bulan dengan berat badan rata-rata 2,5-3 kg. Kemudian hewan coba dibagi dalam 2 kelompok, yakni 5 ekor kelinci kelompok perlakuan diberi PTXF dengan dosis 40 mglkgBB yang diikuti dosis rumatan 1 mglkgBBljam dan 5 ekor kelinci sebagai kontrol diberi cairan NaCl 0,9% dengan kecepatan yang sama seperti kelompok perlakuan. Dilakukan oklusi arteri iliaka komunis sinistra dan setelah 2,5 jam iskemik diambil darah untuk pemeriksaan hematokrit dan viskositas, setelah itu segera diberikan PTXF. Pada jam ke-3 dilakukan reperfusi (membuka oklusi) dan 2 jam setelah reperfusi diambil darah untuk pemeriksaan hematokrit dan viskositas. Data hasil pemeriksaan dianalisis dengan statistik program SPSS 13 dengan menggunakan uji parametrik General Linear Model (GLM) untuk pengukuran berulang. Hasil: Nilai rerata hematokrit kelompok PTXF fase iskemik 37,06+3,88% dan fase reperfusi 34,20+1,90% dengan delta penurunan 2,86%. Nilai rerata hematokrit kelompok nonPTXF fase iskemik 35,88+5,31% dan fase reperfusi 32,90+4,61% dengan delta penurunan 2,98%. Antara pengukuran pertama dan kedua, baik kelompok PTXF dan nonPTXF tidak terdapat perbedaan bermakna (per, i 9 dan p=0,37). Analisis statistik nilai rerata hematokrit antara kelompok PTXF dan nonPTXF tidak terdapat perbedaan bermakna (p=0,74). Nilai rerata viskositas kelompok PTXF fase iskemik 5,25+0,77 ep dan fase referfusi 4,69+0,70 cp dengan delta penurunan 0,558 cp. Nilai rerata viskositas kelompok nonPTXF fase iskemik 4,54+0,48 cp dan fase reperfusi 4,48+1,31 cp dengan delta penurunan 0,066 cp. Antara pengukuran pertama dan kedua, baik, kelompok PTXF dan nonPTXF tidak terdapat perbedaan bermakna secara statistik (p~,26 dan p=0,92). Analisis statistik pada nilai rerata viskositas antara kelompok PTXF dan nonPTXF tidak terdapat perbedaan bermakna (p=0,53). Kesimpulan: Pemberian PTXF pada kelompok perlakuan memperlihatkan hasil tidak bermakna dalam menurunkan nilai hematokrit dan viskositas darah dibanding kelompok kontrol pads keadaan ceders R-I tungkai akut.

---

Background: Complications of revascularization after an ischemic period has attract attention from clinicians since the beginning of 20th century. Acute limb ischemia is an emergency cardiovascular problem and revascularization procedures of ischemic tissue has been documented to worsen tissue damage to the extend of a need for limb amputation. In ischemic reperfusion injury, changes in blood hemorheology occurs (hematocrit, viscosity and eryhtrocyte deformities). Pentoxifylline (PTXF) has the ability to repair reperfusion injury by increasing peripheral blood flow, repairing eryhtrocyte deformities, decreasing blood viscosity dan suppressing platelet agregation.

Objectives: To investigate the effect of pentoxifylline administration toward hemorheology changes in acute limb ischemic reperfusion injury.

Methods: We studied 10 pure strain New Zealand White Rabbit (NZW) age 5 months with mean weight of 2.5-3 kg. The subjects were divided in two groups; 5 of the experimental rabbit were given PTXF 40 mg/kg body weight followed by a maintenance dose of 1 mg/kg body weight/hour, while subjects in the control group received a similar administration of NaCl 0.9%. We performed occlusion of the left common iliac artery and after an ischemic period of 2.5 hours blood samples were taken for hematocrit and viscosity measurement. PTXF were given soon afterward. On the third hour the artery occlusion were opened and after another two hours blood samples were again taken for hematocrit and viscosity measurement. Data analysis were performed by SPSS 13, using parametric test with general linear model (GLM) for repeated measurements.

Results: The mean hematocrit value for the PTXF group in the ischemic period were 37.0613.88%, and in the reperfusion period were 34.2011.90%, with a decrease of 2.86%. The mean hematocrit value for the control group in the ischemic and reperfusion period were 35.8815.31% and 32.90±4.61% , respectively, with a decrease of 2.98%. There were no significant difference between the first and second hematocrit measurements both in the experimental and control group (p-0.19 and p=0.37). Statistical analysis of mean hematocrit value between the two groups also showed no significant difference (p=0.74). The mean viscosity value for the PTXF group in the ischemic period were 5.2510.77 cp and in the reperfusion period were 4.6910.70 cp with a difference of 0.558 cp. The mean viscosity value for the control group in the ischemic and reperfusion period were 4.54±0.8 cp and 4.4811.31 cp, respectively, with a decrease of 0.066 cp. There were no statistically significant difference between the first and second viscosity measurements both in the experimental and control group (p=0.26 and p=0.92). Statistical analysis of mean viscosity value between the two groups also showed no significant difference (p=0.53).

Conclusion: PTXF administration in the experimentally induced acute limb ischemic reperfusion injury in rabbits have no benefits to decrease hematocrit and viscosity values compared to control group."